ICD-10 Coding for B-cell Lymphoproliferative Disorder(C83.3, C83.31, C83.31U)
Comprehensive guide to ICD-10 coding for B-cell lymphoproliferative disorders, including diffuse large B-cell lymphoma and monoclonal B-cell lymphocytosis.
Complete code families applicable to B-cell Lymphoproliferative Disorder
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.3 | Diffuse large B-cell lymphoma | Use when documentation specifies diffuse large B-cell lymphoma without indicating primary CNS involvement. |
|
| D47.2 | Monoclonal gammopathy | Use for asymptomatic monoclonal B-cell populations with no extramedullary involvement. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutB-cell Lymphoproliferative Disorder
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting B-cell Lymphoproliferative Disorder.
Documenting 'lymphocytosis' without specifying monoclonal nature
Impact
Clinical: May lead to incorrect diagnosis and treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to lack of specificity.
Mitigation
Ensure flow cytometry results are included in documentation.
Misclassification of CNS lymphoma as primary without documentation
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Potential non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Query provider to confirm if CNS involvement is primary.
CNS lymphoma coding
Impact
Risk of incorrect coding without 'primary' documentation.
Mitigation
Implement provider queries for clarification.